Cleared Special

K100732 - FORA G30A BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-4241

K100732 is an FDA 510(k) clearance for FORA G30A BLOOD GLUCOSE MONITORING SYSTEM, manufactured by Taidoc Technology Corporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 116-day FDA review.

K100732 · Taidoc Technology Corporation · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
116d
Days
Class 2
Risk

K100732 is an FDA 510(k) clearance for the FORA G30A BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-4241. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Taidoc Technology Corporation (Taipei County, TW). The FDA issued a Cleared decision on July 9, 2010 after a review of 116 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K100732

510(k) Number K100732 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2010
Decision Date July 09, 2010
Days to Decision 116 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 88d · This submission: 116d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 510
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K100732.
WAVESENSE DIABETES MANAGER MODEL VERSION 1.3.4
K101597 · Agamatrix · Oct 2010
ECHO TD-3227 DUAL BLOOD PRESSURE/BLOOD GLUCOSE METER
K092875 · Taidoc Technology Corporation · Aug 2010
AG-608 BLOOD GLUCOSE MONITORING SYSTEM AND AG-610 BLOOD GLUCOSE MONITORING SYSTEM
K093262 · Andon Medical Co., Ltd. · Jul 2010
EASYPLUS MINI R9N SELF MONITORING BLOOD GLUCOSE SYSTEM MODEL EPS10031
K101457 · Eps Bio Technology Corp. · Jul 2010
TD-4277 BLOOD GLUCOSE MONITORING SYSTEM, MODEL 4277
K100322 · Taidoc Technology Corporation · Jun 2010
RIGHTEST BLOOD GLUCOSE MONITORING SYSTEM, MODEL GM550
K092052 · Bionime Corporation · Jun 2010
K100732 · FORA G30A BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-4241
Download PDF FDA Summary Taidoc Technology Cor…